SCHEMBL5259483

SCHEMBL5259483

COc1cc(N)ccc1C1OCCO1.[N]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
GAA P10253 3/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 5/20 0.40
NR4A1 P22736 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 2/20 0.38
IMPDH2 P12268 1/20 0.38
IMPDH1 P20839 1/20 0.38
USP2 O75604 1/20 0.38
CYP19A1 P11511 2/20 0.37
LMNA P02545 1/20 0.37
NR3C1 P04150 1/20 0.36
DRD4 P21917 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL829699 0.98 MAPT (0.44) MAPTGAATSHRMAPK1HTT
SCHEMBL7090123 0.85 KDM4E (0.42) MAPTGAATSHRMAPK1HTT
SCHEMBL27438368 0.79 ACHE (0.48) MAPTGAAMAPK1ALDH1A1NPC1
SCHEMBL15783799 0.79 KDM4E (0.41) TSHRMAPK1KDM4EALDH1A1NPC1
SCHEMBL1704526 0.78 NPC1 (0.39) HTTKDM4EALDH1A1NPC1RAB9A
SCHEMBL25384440 0.78 KDM4E (0.45) MAPTGAAKDM4EALDH1A1NPC1
SCHEMBL15783792 0.75 ACHE (0.44) MAPTMAPK1HTTALDH1A1NPC1
SCHEMBL28338806 0.75 NPC1 (0.38) GAAHTTALDH1A1NPC1RAB9A
SCHEMBL22170394 0.75 MAPT (0.42) MAPTGAATSHRMAPK1HTT
SCHEMBL2570589 0.75 MAPT (0.48) MAPTGAATSHRMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833822-A2 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance, Inc. (US) 2007-09-19 EP disclosed
WO-2006023460-A2 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE, INC. (US) 2006-03-02 WO disclosed